Parvovirus B19 infection

Seminars in Fetal and Neonatal Medicine

Volumn 14, Issue 4, 2009, Pages 218-221

  Tolfvenstam, Thomas ^a   Broliden, Kristina ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Congenital infection; Erythrovirus; Human parvovirus B19; Pregnancy; Prenatal diagnosis

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; VIRUS VACCINE;

ANEMIA; ARTICLE; COUNSELING; ERYTHEMA INFECTIOSUM; FETUS DEATH; FETUS HYDROPS; HUMAN; IMMUNITY; INTERVENTION STUDY; MONITORING; MORTALITY; MOTHER; PARVOVIRUS; PASSIVE IMMUNIZATION; PATHOGENESIS; SECOND TRIMESTER PREGNANCY; SOCIETY; SYMPTOM; THIRD TRIMESTER PREGNANCY; VIRUS TRANSMISSION;

FEMALE; HUMANS; HYDROPS FETALIS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 67349088398     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2009.01.007     Document Type: Article

References (89)

1. Cohen B.J., and Buckley M.M. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 25 (1988) 151-153
2. Cossart Y.E., Field A.M., Cant B., and Widdows D. Parvovirus-like particles in human sera. Lancet 1 7898 (1975) 72-73
3. Ozawa K., Kurtzman G., and Young N. Replication of the B19 parvovirus in human bone marrow cell cultures. Science 233 4766 (1986) 883-886
4. Cotmore S.F., and Tattersall P. Characterization and molecular cloning of a human parvovirus genome. Science 226 4679 (1984) 1161-1165
5. Gallinella G., Venturoli S., Manaresi E., Musiani M., and Zerbini M. B19 virus genome diversity: epidemiological and clinical correlations. J Clin Virol 28 (2003) 1-13
6. Servant A., Laperche S., Lallemand F., et al. Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 76 (2002) 9124-9134
7. Jones M.S., Kapoor A., Lukashov V.V., et al. New DNA viruses identified in patients with acute viral infection syndrome. J Virol 79 (2005) 8230-8236
8. Simmonds P., Douglas J., Bestetti G., et al. A third genotype of the human parvovirus PARV4 in sub-Saharan Africa. J Gen Virol 89 Pt 9 (2008) 2299-2302
9. Allander T., Tammi M.T., Eriksson M., et al. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci U S A 102 (2005) 12891-12896
10. Anand A., Gray E.S., Brown T., Clewley J.P., and Cohen B.J. Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med 316 (1987) 183-186
11. Broliden K. Parvovirus B19 infection in pediatric solid-organ and bone marrow transplantation. Pediatr Transplant 5 (2001) 320-330
12. Jordan J., Tiangco B., Kiss J., and Koch W. Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients. Vox Sang 75 (1998) 97-102
13. Anderson L.J., Tsou C., Parker R.A., et al. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol 24 (1986) 522-526
14. Schwarz T.F., Gurtler L.G., Zoulek G., Deinhardt F., and Roggendorf M. Seroprevalence of human parvovirus B19 infection in Sao Tome and Principe, Malawi and Mascarene Islands. Zentralbl Bakteriol 271 (1989) 231-236
15. Tolfvenstam T., Enbom M., Ghebrekidan H., et al. Seroprevalence of viral childhood infections in Eritrea. J Clin Virol 16 (2000) 49-54
16. de Freitas R.B., Wong D., Boswell F., et al. Prevalence of human parvovirus (B19) and rubella virus infections in urban and remote rural areas in northern Brazil. J Med Virol 32 (1990) 203-208
17. Kleinman S.H., Glynn S.A., Lee T.H., et al. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay. Transfusion 47 (2007) 1756-1764
18. Thomas I., Di Giambattista M., Gerard C., et al. Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins. Vox Sang 84 (2003) 300-307
19. Tsujimura M., Matsushita K., Shiraki H., et al. Human parvovirus B19 infection in blood donors. Vox Sang 69 (1995) 206-212
20. Yoto Y., Kudoh T., Haseyama K., et al. Incidence of human parvovirus B19 DNA detection in blood donors. Br J Haematol 91 (1995) 1017-1018
21. Lindblom A., Heyman M., Gustafsson I., et al. Parvovirus B19 infection in children with acute lymphoblastic leukemia is associated with cytopenia resulting in prolonged interruptions of chemotherapy. Clin Infect Dis 46 (2008) 528-536
22. Broliden K., Tolfvenstam T., Ohlsson S., and Henter J.I. Persistent B19 parvovirus infection in pediatric malignancies. Med Pediatr Oncol 31 (1998) 66-72
23. Heegaard E.D., and Taaning E.B. Parvovirus B19 and parvovirus V9 are not associated with Henoch-Schönlein purpura in children. Pediatr Infect Dis J 21 (2002) 31-34
24. Lundqvist A., Tolfvenstam T., Brytting M., et al. Prevalence of parvovirus B19 DNA in bone marrow of patients with haematological disorders. Scand J Infect Dis 31 (1999) 119-122
25. Anderson M.J., and Cohen B.J. Human parvovirus B19 infections in United Kingdom 1984-86. Lancet 1 8535 (1987) 738-739
26. Gilbert N.L., Gyorkos T.W., Beliveau C., et al. Seroprevalence of parvovirus B19 infection in daycare educators. Epidemiol Infect 133 (2005) 299-304
27. Anderson L.J. Role of parvovirus B19 in human disease. Pediatr Infect Dis J 6 (1987) 711-718
28. Anderson L.J., Gillespie S.M., Torok T.J., et al. Risk of infection following exposures to human parvovirus B19. Behring Inst Mitt 85 (1990) 60-63
29. Gillespie S.M., Cartter M.L., Asch S., et al. Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum. J Am Med Assoc 263 (1990) 2061-2065
30. Woolf A.D., Campion G.V., Chishick A., et al. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med 149 (1989) 1153-1156
31. Yaegashi N., Niinuma T., Chisaka H., et al. The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection; report of 10 cases and meta-analysis. J Infect 37 (1998) 28-35
32. Kerr J.R., O'Neill H.J., Coyle P.V., and Thompson W. An outbreak of parvovirus B19 infection; a study of clinical manifestations and the incidence of fetal loss. Ir J Med Sci 163 (1994) 65-67
33. Kinney J.S., Anderson L.J., Farrar J., et al. Risk of adverse outcomes of pregnancy after human parvovirus B19 infection. J Infect Dis 157 (1988) 663-667
34. Harger J.H., Adler S.P., Koch W.C., and Harger G.F. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms. Obstet Gynecol 91 (1998) 413-420
35. Beigi R.H., Wiesenfeld H.C., Landers D.V., and Simhan H.N. High rate of severe fetal outcomes associated with maternal parvovirus b19 infection in pregnancy. Infect Dis Obstet Gynecol 2008 (2008) 524601
36. Jensen I.P., Thorsen P., Jeune B., Moller B.R., and Vestergaard B.F. An epidemic of parvovirus B19 in a population of 3,596 pregnant women: a study of sociodemographic and medical risk factors. Br J Obstet Gynaecol 107 (2000) 637-643
37. Guidozzi F., Ballot D., and Rothberg A.D. Human B19 parvovirus infection in an obstetric population. A prospective study determining fetal outcome. J Reprod Med 39 (1994) 36-38
38. Anonymous. Prospective study of human parvovirus (B19) infection in pregnancy. Public Health Laboratory Service Working Party on Fifth Disease. Br Med J 300 6733 (1990) 1166-1170
39. Brown T., Anand A., Ritchie L.D., Clewley J.P., and Reid T.M. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet 2 8410 (1984) 1033-1034
40. Jordan J.A. Identification of human parvovirus B19 infection in idiopathic nonimmune hydrops fetalis. Am J Obstet Gynecol 174 1 Pt 1 (1996) 37-42
41. Garcia A.G., Pegado C.S., Cubel Rde C., et al. Feto-placentary pathology in human parvovirus B19 infection. Rev Inst Med Trop Sao Paulo 40 (1998) 145-150
42. Nunoue T., Kusuhara K., and Hara T. Human fetal infection with parvovirus B19: maternal infection time in gestation, viral persistence and fetal prognosis. Pediatr Infect Dis J 21 (2002) 1133-1136
43. Nyman M., Skjoldebrand-Sparre L., and Broliden K. Non-hydropic intrauterine fetal death more than 5 months after primary parvovirus B19 infection. J Perinat Med 33 (2005) 176-178
44. Sheikh A.U., Ernest J.M., and O'Shea M. Long-term outcome in fetal hydrops from parvovirus B19 infection. Am J Obstet Gynecol 167 (1992) 337-341
45. Riipinen A., Vaisanen E., Nuutila M., et al. Parvovirus B19 infection in fetal deaths. Clin Infect Dis 47 (2008) 1519-1525
46. Enders M., Weidner A., Zoellner I., Searle K., and Enders G. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 24 (2004) 513-518
47. Miller E., Fairley C.K., Cohen B.J., and Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 105 (1998) 174-178
48. Norbeck O., Papadogiannakis N., Petersson K., et al. Revised clinical presentation of parvovirus B19-associated intrauterine fetal death. Clin Infect Dis 35 (2002) 1032-1038
49. Skjoldebrand-Sparre L., Tolfvenstam T., Papadogiannakis N., et al. Parvovirus B19 infection: association with third-trimester intrauterine fetal death. Br J Obstet Gynaecol 107 (2000) 476-480
50. Syridou G., Spanakis N., Konstantinidou A., et al. Detection of cytomegalovirus, parvovirus B19 and herpes simplex viruses in cases of intrauterine fetal death: association with pathological findings. J Med Virol 80 (2008) 1776-1782
51. Tolfvenstam T., Papadogiannakis N., Norbeck O., Petersson K., and Broliden K. Frequency of human parvovirus B19 infection in intrauterine fetal death. Lancet 357 9267 (2001) 1494-1497
52. Nyman M., Tolfvenstam T., Petersson K., et al. Detection of human parvovirus B19 infection in first-trimester fetal loss. Obstet Gynecol 99 5 Pt 1 (2002) 795-798
53. Jordan J.A., and DeLoia J.A. Globoside expression within the human placenta. Placenta 20 (1999) 103-108
54. Berry P.J., Gray E.S., Porter H.J., and Burton P.A. Parvovirus infection of the human fetus and newborn. Semin Diagn Pathol 9 (1992) 4-12
55. Morey A.L., Keeling J.W., Porter H.J., and Fleming K.A. Clinical and histopathological features of parvovirus B19 infection in the human fetus. Br J Obstet Gynaecol 99 (1992) 566-574
56. Jordan J.A., Huff D., and DeLoia J.A. Placental cellular immune response in women infected with human parvovirus B19 during pregnancy. Clin Diagn Lab Immunol 8 (2001) 288-292
57. Jordan J.A., and Butchko A.R. Apoptotic activity in villous trophoblast cells during B19 infection correlates with clinical outcome: assessment by the caspase-related M30 Cytodeath antibody. Placenta 23 (2002) 547-553
58. von Kaisenberg C.S., Bender G., Scheewe J., et al. A case of fetal parvovirus B19 myocarditis, terminal cardiac heart failure, and perinatal heart transplantation. Fetal Diagn Ther 16 (2001) 427-432
59. Bultmann B.D., Klingel K., Nabauer M., Wallwiener D., and Kandolf R. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol 193 (2005) 363-365
60. Shneerson J.M., Mortimer P.P., and Vandervelde E.M. Febrile illness due to a parvovirus. Br Med J 280 6231 (1980) 1580
61. de Jong E.P., de Haan T.R., Kroes A.C., et al. Parvovirus B19 infection in pregnancy. J Clin Virol 36 (2006) 1-7
62. Enders M., Schalasta G., Baisch C., et al. Human parvovirus B19 infection during pregnancy - value of modern molecular and serological diagnostics. J Clin Virol 35 (2006) 400-406
63. Dieck D., Schild R.L., Hansmann M., and Eis-Hubinger A.M. Prenatal diagnosis of congenital parvovirus B19 infection: value of serological and PCR techniques in maternal and fetal serum. Prenat Diagn 19 (1999) 1119-1123
64. Skjoldebrand-Sparre L., Nyman M., Broliden K., and Wahren B. All cases of intrauterine fetal death should be evaluated for parvovirus B19 viral deoxyribonucleic acid. Am J Obstet Gynecol 180 6 Pt 1 (1999) 1595-1596
65. Petersson K., Norbeck O., Westgren M., and Broliden K. Detection of parvovirus B19, cytomegalovirus and enterovirus infections in cases of intrauterine fetal death. J Perinat Med 32 (2004) 516-521
66. Wolff K., Broliden K., Marsk A., et al. One stillborn and one severely hydropic twin due to parvovirus B19 infection; successful outcome of the surviving twin. Acta Obstet Gynecol Scand 78 (1999) 828-830
67. Knoll A., Louwen F., Kochanowski B., et al. Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR). J Med Virol 67 (2002) 259-266
68. Enders M., Weidner A., Rosenthal T., et al. Improved diagnosis of gestational parvovirus B19 infection at the time of nonimmune fetal hydrops. J Infect Dis 197 (2008) 58-62
69. Prowse C., Ludlam C.A., and Yap P.L. Human parvovirus B19 and blood products. Vox Sang 72 (1997) 1-10
70. Lindblom A., Isa A., Norbeck O., et al. Slow clearance of human parvovirus B19 viremia following acute infection. Clin Infect Dis 41 (2005) 1201-1203
71. Lefrere J.J., Servant-Delmas A., Candotti D., et al. Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood 106 (2005) 2890-2895
72. Landolsi H, Yacoubi MT, Bouslama L, et al. Detection of the human Parvovirus B19 in nonimmune hydrops fetalis using immunohistochemistry and nested-PCR in formalin-fixed and paraffin-embedded placenta and fetal tissues Pathol Biol (Paris) in press, doi:10.1016/j.patbio.2007.11.001
73. Ballou W.R., Reed J.L., Noble W., Young N.S., and Koenig S. Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1. J Infect Dis 187 (2003) 675-678
74. Valeur-Jensen A.K., Pedersen C.B., Westergaard T., et al. Risk factors for parvovirus B19 infection in pregnancy. J Am Med Assoc 281 (1999) 1099-1105
75. Cosmi E., Mari G., Delle Chiaie L., et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia resulting from parvovirus infection. Am J Obstet Gynecol 187 (2002) 1290-1293
76. Delle Chiaie L., Buck G., Grab D., and Terinde R. Prediction of fetal anemia with Doppler measurement of the middle cerebral artery peak systolic velocity in pregnancies complicated by maternal blood group alloimmunization or parvovirus B19 infection. Ultrasound Obstet Gynecol 18 (2001) 232-236
77. Bond P.R., Caul E.O., Usher J., et al. Intrauterine infection with human parvovirus. Lancet 1 8478 (1986) 448-449
78. Gray E.S., Anand A., and Brown T. Parvovirus infections in pregnancy. Lancet 1 8474 (1986) 208
79. Brennand J.E., and Cameron A.D. Human parvovirus B19 in pregnancy. Hosp Med 61 (2000) 93-96
80. Rodis J.F., Borgida A.F., Wilson M., et al. Management of parvovirus infection in pregnancy and outcomes of hydrops: a survey of members of the Society of Perinatal Obstetricians. Am J Obstet Gynecol 179 (1998) 985-988
81. von Kaisenberg C.S., and Jonat W. Fetal parvovirus B19 infection. Ultrasound Obstet Gynecol 18 (2001) 280-288
82. Schild R.L., Bald R., Plath H., et al. Intrauterine management of fetal parvovirus B19 infection. Ultrasound Obstet Gynecol 13 (1999) 161-166
83. Smoleniec J.S., and Pillai M. Management of fetal hydrops associated with parvovirus B19 infection. Br J Obstet Gynaecol 101 (1994) 1079-1081
84. Forestier F., Tissot J.D., Vial Y., Daffos F., and Hohlfeld P. Haematological parameters of parvovirus B19 infection in 13 fetuses with hydrops foetalis. Br J Haematol 104 (1999) 925-927
85. Selbing A., Josefsson A., Dahle L.O., and Lindgren R. Parvovirus B19 infection during pregnancy treated with high-dose intravenous gammaglobulin. Lancet 345 8950 (1995) 660-661
86. Matsuda H., Sakaguchi K., Shibasaki T., et al. Intrauterine therapy for parvovirus B19 infected symptomatic fetus using B19 IgG-rich high titer gammaglobulin. J Perinat Med 33 (2005) 561-563
87. Gigler A., Dorsch S., Hemauer A., et al. Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins. J Virol 73 (1999) 1974-1979
88. Cohen B.J., and Kumar S. Parvovirus B19 infection in pregnancy. Fetal Matern Med Rev 16 (2005) 123-150
89. Nagel H.T., de Haan T.R., Vandenbussche F.P., Oepkes D., and Walther F.J. Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection. Obstet Gynecol 109 (2007) 42-47